Top

Published in:

01-04-2011

Obesity, Age, and Cardiac Risk

Authors: Surya M. Artham, Carl J. Lavie, Alban De Schutter, Hector O. Ventura, Richard V. Milani

Published in: Current Cardiovascular Risk Reports | Issue 2/2011

Abstract

Obesity is a highly prevalent metabolic disorder affecting all sections of society from young children to adults and the elderly. Obesity is a well-established risk factor for several conventional cardiovascular (CV) risk factors such as hypertension (HTN), type 2 diabetes mellitus, and dyslipidemia. Obesity is also a very potent independent risk factor for CV diseases (CVD), including coronary heart disease (CHD), heart failure (HF), peripheral arterial disease (PAD), atrial fibrillation (AF), and sudden cardiac death (SCD), and is also associated with increased CV and all-cause morbidity. Despite this adverse association between obesity and CV risk factors and several CVDs, numerous studies have identified the phenomenon called the “obesity paradox” or “reverse epidemiology”, meaning better short- and long-term survival in overweight and obese subjects with HTN, HF, CHD, PAD, and AF. This review summarizes the adverse impact of obesity on CV risk factors and CVDs, effects of obesity and aging in the elderly, and the puzzling phenomenon of the “obesity paradox” in the above-mentioned special populations and the elderly.

Poirier P, Giles TD, Bray GA, et alObesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898–918.PubMedCrossRef

•• Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925–1932. This details the impact of obesity on CHD, HF, HTN, and other CVDs, and the phenomenon called the “obesity paradox” and the weight reduction status. PubMedCrossRef

Flegal KM, Carroll MD, Ogden CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002, 288:1723–1727.PubMedCrossRef

Lavie CJ, Milani RV. Obesity and cardiovascular disease: the Hippocrates paradox? J Am Coll Cardiol 2003, 42:677–679.PubMedCrossRef

American Obesity Association. AOA Fact Sheets: Obesity in the U.S.Washington, DC: American Obesity Association; 2002. Available at: http://www.obesity.org/subs/fastfacts/obesity_US.shtml. Accessed October 2010

World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva: WHO; 1999.

US Department of Health and Human Services. The Surgeon General’s Call to Action to Prevent and Decrease Overweight and Obesity. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General: 2001.

Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005, 352:1138–1145.PubMedCrossRef

National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998(suppl 2):51S–209S.

10.

Manson JE, Bassuk SS. Obesity in the United States: a fresh look at its high toll. JAMA 2003, 289:229–230.PubMedCrossRef

11.

Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med 2008, 120:34–41.PubMedCrossRef

12.

Lavie CJ, Milani RV, Ventura HO. Untangling the heavy cardiovascular burden of obesity. Nat Clin Pract Cardiovasc Med 2008, 5:428–429.PubMedCrossRef

13.

Artham SM, Lavie CJ, Patel HM, Ventura HO. Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr. 2008, 3:155–161.PubMedCrossRef

14.

Lavie CJ, Milani RV, Messerli FH. From obesity, hypertension, and left ventricular hypertrophy to heart failure. Ochsner J. 2002, 2(suppl):s8–s14.

15.

•• Artham SM, Lavie CJ, Patel DA, Ventura HO. Obesity paradox in the elderly: is fatter really fitter? Aging Health 2009, 5:177–184. This details the obesity paradox in the elderly population, implications of obesity, and recommendations for weight loss. CrossRef

16.

Miller TM, Lavie CJ, White CJ. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr 2008, 3:162–167.CrossRef

17.

Lavie CJ, Osman AF, Milani RV, Mehra MR, Body composition and prognosis in chronic systolic heart failure—the obesity paradox. Am J Cardiol, 2003 91:891–894.PubMedCrossRef

18.

Curtis JP, Selter JG, Wang Y et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005, 165:55–61.PubMedCrossRef

19.

Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 2005, 26:5–7.PubMedCrossRef

20.

Horwich TB, Fonarow GC, Hamilton MA et al., The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001, 38:789–795.PubMedCrossRef

21.

Uretsky S, Messerli FH, Bangalore S et al., Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007, 120:863–870.PubMedCrossRef

22.

Lavie CJ, Milani RV, Ventura HO. Obesity, heart disease, and favorable prognosis—truth or paradox? Am J Med 2007, 120:825–826.PubMedCrossRef

23.

Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox and discrepancy between peak oxygen consumption and heart failure prognosis—it’s all in the fat. Congest Heart Fail 2007, 13:177–180.PubMedCrossRef

24.

Lavie CJ, Milani RV, Ventura HO et al., Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007, 100:1460–1464.PubMedCrossRef

25.

Artham SM, Lavie CJ, Milani RV, Ventura HO: Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. The Ochsner Journal 2009, 9:124–132.

26.

•• Lavie CJ, Milani RV, Artham SM, et al: The obesity paradox, weight loss, and coronary disease. Am J Med 2009, 122:1106–1114. This retrospective analysis in a CRET sample identified a positive association between BMI and percent body fat and survival. It also reported the many benefits of CRET on multiple CV risk factors. PubMedCrossRef

27.

Galal W, Van Gestel Y, Hoeks SE, et al. The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease. Chest 2009, 134:925–930.CrossRef

28.

Lavie CJ, Ventura HO, Milani RV. The “obesity paradox”—is smoking/lung disease the explanation? Chest 2009, 134:896–898.CrossRef

29.

Kalantar-Zadeh K, Streja E, Kovesdy CP, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc. 2010, 85:991–1001.PubMedCrossRef

30.

• Wanahita N, Messerli FH, Bangalore S, et al. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 2008, 155:310–315. This meta-analysis of 16 studies with 123,249 individuals identified a 49% increase in the risk of AF in obese individuals compared to non-obese individuals. PubMedCrossRef

31.

•• Badheka AO, Rathod A, Kizilbash M, et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 2010, 123:646–651. In this post-hoc analysis of the AFFIRM database in 2492 individuals, it was observed that overweight and obese AF patients had lower all-cause and CV mortality compared to normal-weight patients, which demonstrates the obesity paradox in the AF population. PubMedCrossRef

32.

Heiat A, Vacccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001, 161:1194–1203.PubMedCrossRef

33.

Ho SC. Health and social predictors of mortality in an elderly Chinese cohort. Am J Epidemiol 1991, 133:907–921.PubMed

34.

Romero-Corral A, Somers VK, Sierra-Johnson J et al., Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J 2007, 28:2087–2093.PubMedCrossRef

35.

de Koning L, Merchant AT, Pogue J, et al. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007, 28:850–856.PubMedCrossRef

36.

Romero-Corral A, Lopez-Jimenez F, Sierra-Johnson J. Differentiating between body fat and lean mass—how should we measure obesity?, Nat Clin Pract Endocrinol Metab. 2008, 4:322–323.PubMedCrossRef

37.

Lavie CJ, Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest 1986, 90:275–279.PubMedCrossRef

38.

Messerli FH. Cardiovascular effects of obesity and hypertension. Lancet 1982, 1:1165–1168.PubMedCrossRef

39.

Lavie CJ, Ventura HO, Messerli FH. Left ventricular hypertrophy: its relationship to obesity and hypertension. Postgrad Med 1992, 91:131–143.PubMed

40.

Milani RV, Lavie CJ, Mehra MR, Ventura HO, et al. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol 2006, 97:959–963.PubMedCrossRef

41.

Kenchaiah S, Evans JC, Levy D, et al Obesity and the risk of heart failure. N Engl J Med 2002, 347:305–313.PubMedCrossRef

42.

Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000, 8:605–619.PubMedCrossRef

43.

Lavie CJ, Amodeo C, Ventura HO, et al. Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity. Chest 1987, 92:1042–1046.PubMedCrossRef

44.

Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 1977, 39:452–458.PubMedCrossRef

45.

Hubert HB, Feinleib M, McNamara PM et al.Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968–977.PubMed

46.

Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990, 322:882–889.PubMedCrossRef

47.

McGill Jr HC, McMahan CA, Herderick EE, et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002, 105:2712–2718.PubMedCrossRef

48.

Madala MC, Franklin BA, Chen AY, et al. Obesity and age of first Non-ST segment elevation myocardial infarction. J Am Coll Cardiol 2008, 52:979–985.PubMedCrossRef

49.

Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004, 292:2471–2477.PubMedCrossRef

50.

Tsang TS, Barnes ME, Miyasaka Y, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 2008, 29:2227–2233.PubMedCrossRef

51.

Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham Study. Am Heart J 1988, 115:869–875.PubMedCrossRef

52.

el-Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol 1995, 75:956–959.PubMedCrossRef

53.

Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002, 162:2557–2562.PubMedCrossRef

54.

Trollo PJ Jr., Rogers RM. Obstructive sleep apnea. N Engl J Med 1996, 334:99–104.CrossRef

55.

Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988, 94:1200–1204.

56.

Lavie CJ, Milani RV, Artham SM, et al. Does body composition impact survival in patients with advance heart failure (abstr). Circulation 2007, 116: II360.CrossRef

57.

Fonarow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in acute decompensated heart failure national registry. Am Heart J 2007, 153:74–81PubMedCrossRef

58.

•• Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13–22. This meta-analysis of nine observational studies in 28,209 HF patients noted that overweight and obese subjects had lower all-cause and CV mortality compared to normal-weight subjects. PubMedCrossRef

59.

Oreopoulos A, Ezekowitz JA, McAlister FA, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 2010, 85:609–617.PubMedCrossRef

60.

Lavie CJ, Milani RV, Ventura Ho, et al. Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the “obesity paradox”. Mayo Clin Proc 2010, 85:605–608.PubMedCrossRef

61.

Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666–678.PubMedCrossRef

62.

Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002, 39:578–584.PubMedCrossRef

63.

Buettner HJ, Mueller C, Gick M, et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 2007, 28:1694–1701.PubMedCrossRef

64.

Wassertheil-Smoller S, Fann C, Allman RM, et al. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med 2000, 160:494–500.PubMedCrossRef

65.

Stamler R, Ford CE, Stamler J. Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program. Hypertension 1991, 17:553–564.PubMed

66.

•• McAuley PA, Kokkinos PF, Oliveira RB, et al. Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years. Mayo Clin Proc 2010, 85:115–121. The investigators evaluated the influence of cardiorespiratory fitness on the obesity paradox in male veterans with known or suspected CHD. Fitness significantly altered the obesity paradox; overweight and obese men had better survival only if they had the highest level of fitness. PubMedCrossRef

67.

Ades PA, Savage PD. The obesity paradox: perception vs knowledge. Mayo Clin Proc 2010, 85:112–114.PubMedCrossRef

68.

Mehra MR, Uber PA, Parh MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004, 43:1590–1595.PubMedCrossRef

69.

Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85–151.PubMedCrossRef

70.

Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obs Relat Metab Disord. 1998, 22:39–47.CrossRef

71.

Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21–181.PubMedCrossRef

72.

Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005, 293:1861–1867.PubMedCrossRef

73.

Takata Y, Ansai T, Soh I, et al. Association between body mass index and mortality in an 80 year-old population. J Am Geriatr Soc 2007, 55:913–917.PubMedCrossRef

74.

Heiat A, Vaccarino V, Krumholz HM: An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001, 161:1194–1203.PubMedCrossRef

75.

Janssen I, Mark AE: Elevated body mass index and mortality risk in the elderly. Obes Rev 2007, 8:41–59.PubMedCrossRef

76.

•• Lavie CJ, Milani RV, Patel DK, Artham SM, Ventura HO. Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function. Postgrad Med 2009, 121:119–125. Investigators analyzed the differential impact of LV geometric patterns and BMI in elderly subjects (> 70 years) on mortality. Increasing BMI was directly associated with better survival, supporting the obesity paradox phenomenon. However, in each BMI subgroup there was a progressive increase in mortality from normal to abnormal LV geometric patterns. PubMedCrossRef

77.

•• Artham SM, Lavie CJ, Milani RV, Ventura HO. Value of weight reduction in patients with cardiovascular disease. Curr Treat Options Cardiovasc Med 2010, 12:21–35. This article summarizes the importance of weight reduction in various CV populations, emphasizing the pharmacologic and surgical therapeutic options. PubMedCrossRef

78.

Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000,133:92–103.PubMed

79.

Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care. 2010, 33:1957–1969.PubMedCrossRef

80.

Poobalan A, Aucott L, Smith WC, et al. Effects of weight loss in overweight/obese individuals and long-term lipid outcomes—a systematic review. Obes Rev 2004, 5:43–50.PubMedCrossRef

81.

Richette P, Poitou C, Gamero P, et al "Beneficial effects of massive weight loss on symptoms, joint biomarkers and systemic inflammation in obese patients with knee osteoarthritis" Ann Rheum Dis 2010; 69: 107.

82.

Lavie CJ, Milani RV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 1997, 79:397–401.PubMedCrossRef

83.

Lavie CJ, Milani RV. Exercise training in special populations: obesity. In:Wenger NK, Smith LK, Froelicher ES, Comoss PM, eds. Cardiac Rehabilitation: A Guide to Practice in the 21st Century. New York: Marcel Dekker Inc.; 1999:151–154.

84.

• Sierra-Johnson J, Romero-Corral A, Somers VK, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil 2008, 15:336–340. This prospective study in 377 CHD patients from a CRET program assessed the impact of weight loss on mortality and acute CV events. Over a mean follow-up of 6.4 years, the group with a weight loss had better long-term outcomes compared to the group with no weight loss, and this benefit was noted regardless of the initial BMI. PubMedCrossRef

85.

•• Ades PA, Savage PD, Toth MJ, et al. High-calorie expenditure exercise. A new approach to cardiac rehabilitation for overweight coronary patients. Circulation 2009, 119: 2671–2678. This randomized study noted that the high-calorie expenditure CRET program promotes greater weight loss and more favorable CV risk factors compared to standard CRET in overweight and obese coronary patients. PubMedCrossRef

Title: Obesity, Age, and Cardiac Risk
Authors: Surya M. Artham
Carl J. Lavie
Alban De Schutter
Hector O. Ventura
Richard V. Milani
Publication date: 01-04-2011
Publisher: Current Science Inc.
Published in: Current Cardiovascular Risk Reports / Issue 2/2011
Print ISSN: 1932-9520
Electronic ISSN: 1932-9563
DOI: https://doi.org/10.1007/s12170-011-0155-7

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Obesity, Age, and Cardiac Risk

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Red Meat Intake and the Risk of Cardiovascular Disease

Carotid Intima Media Thickness Versus Carotid Plaque in Cardiovascular Risk Evaluation

The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging Biomarkers

Fitness, Fatness, and Cardiovascular Disease Risk and Outcomes

Does the 9p21 Genetic Variant Have a Role in Cardiovascular Risk Prediction?

Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page